PAK1 and non-small cell lung carcinoma: TGFBR1 subsequently activates downstream targets via a noncanonical pathway, including the P21-activated kinase 1 (PAK1), mitogen-activated protein kinase (MAPK) and PI3K/AKT pathways in NSCLC [37].